autologous cord blood-derived mononuclear cells (BrainRepair)

N/A

Report date: 2025/03/18 20:00:05

Base Information

Drug Nameautologous cord blood-derived mononuclear cells (BrainRepair)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy
Mechanisms of ActionNeuroprotectants
TargetsUpdating
Therapy Area/IndicationsLeukomalacia, PeriventricularBrain Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryEurope
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBrainRepair UG
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBrainRepair UG
Active IndicationsN/A
Inactive IndicationsLeukomalacia, PeriventricularBrain Diseases

Other Information

ATC CodeN/A
Related LinksN/A